These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2137886

  • 1. Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels.
    Imura Y, Terashita Z, Shibouta Y, Inada Y, Nishikawa K.
    Jpn J Pharmacol; 1990 Jan; 52(1):35-43. PubMed ID: 2137886
    [Abstract] [Full Text] [Related]

  • 2. [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi].
    Itoh Y, Shindoh J, Horiba M, Kohno S, Ohata K, Ashida Y, Takagi K.
    Arerugi; 1993 Nov; 42(11):1670-6. PubMed ID: 8279967
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and thromboxane A2/prostaglandin H2 receptor antagonistic activity of phenol derivatives.
    Fukumoto S, Shiraishi M, Terashita Z, Ashida Y, Inada Y.
    J Med Chem; 1992 Jun 12; 35(12):2202-9. PubMed ID: 1535377
    [Abstract] [Full Text] [Related]

  • 4. The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor.
    Imura Y, Terashita Z, Shibouta Y, Nishikawa K.
    Eur J Pharmacol; 1988 Mar 15; 147(3):359-65. PubMed ID: 2967770
    [Abstract] [Full Text] [Related]

  • 5. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep 15; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 6. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P, White BP, Humphrey PP.
    Br J Pharmacol; 1989 Jul 15; 97(3):783-94. PubMed ID: 2527074
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 15; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 8. Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation.
    Shiraishi M, Kato K, Terao S, Ashida Y, Terashita Z, Kito G.
    J Med Chem; 1989 Sep 15; 32(9):2214-21. PubMed ID: 2769691
    [Abstract] [Full Text] [Related]

  • 9. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids.
    Ashida Y, Matsumoto T, Kuriki H, Shiraishi M, Kato K, Terao S.
    Prostaglandins; 1989 Jul 15; 38(1):91-112. PubMed ID: 2748922
    [Abstract] [Full Text] [Related]

  • 10. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 11. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov 15; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic properties of KT2-962 (6-isopropyl-3-[4-(p- chlorobenzenesulfonylamino)-butyl]-azulene-1-sulfonic acid sodium salt); a new TXA2/prostaglandin endoperoxide receptor antagonist.
    Kosakai K, Wakabayashi S, Sato T, Mochizuki S, Tomiyama A, Zhou Q, Satake N, Shibata S.
    J Cardiovasc Pharmacol; 1993 Mar 15; 21(3):441-7. PubMed ID: 7681506
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM, Jones RL, Wilson NH, Marr CG.
    Br J Pharmacol; 1991 Mar 15; 102(3):607-14. PubMed ID: 1364826
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S, Whittle BJ.
    Br J Pharmacol; 1986 Aug 15; 88(4):931-6. PubMed ID: 3017497
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec 15; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 16. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets.
    Halushka PV, Mais DE, Garvin M.
    Eur J Pharmacol; 1986 Nov 12; 131(1):49-54. PubMed ID: 3816947
    [Abstract] [Full Text] [Related]

  • 17. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A, Shirakura S, Higo K, Kubo K.
    Arzneimittelforschung; 1991 Dec 12; 41(12):1237-41. PubMed ID: 1815522
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 19. Platelet endoperoxide/thromboxane A2 (PGH2/TXA2) receptors in patients with myeloproliferative disorders.
    Faul C, Renn W, Jaschonek K.
    Prostaglandins Leukot Essent Fatty Acids; 1991 Aug 01; 43(4):273-6. PubMed ID: 1835097
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    Ogletree ML, Harris DN, Schumacher WA, Webb ML, Misra RN.
    J Pharmacol Exp Ther; 1993 Feb 01; 264(2):570-8. PubMed ID: 8437108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.